NanoRepro AG (FRA:NN6) Change In Receivables: €0.00 Mil (TTM As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:NN6 NanoRepro AG FRA:NN6
70 GF Score
Price €1.78
GF Value €1.07
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is NanoRepro AG Change In Receivables?

NanoRepro AG FRA:NN6 +10.90% 70 Change In Receivables is €0.00 Mil as of Jun. 2025. GuruFocus rates FRA:NN6 with a GF Score™ of 70/100 and a GF Value™ of €1.07 (Significantly Overvalued). The stock has 3 warning signs investors should review.

NanoRepro AG's change in receivables for the quarter that ended in Jun. 2025 was €0.00 Mil. It means NanoRepro AG's Accounts Receivable stayed the same from Dec. 2024 to Jun. 2025 .

NanoRepro AG's change in receivables for the fiscal year that ended in Dec. 2024 was €0.00 Mil. It means NanoRepro AG's Accounts Receivable stayed the same from Dec. 2023 to Dec. 2024 .

NanoRepro AG's Accounts Receivable for the quarter that ended in Jun. 2025 was €0.43 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. NanoRepro AG's Days Sales Outstanding for the six months ended in Jun. 2025 was 30.38.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. NanoRepro AG's liquidation value for the six months ended in Jun. 2025 was €7.15 Mil.

NanoRepro AG  (FRA:NN6) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

NanoRepro AG's Days Sales Outstanding for the quarter that ended in Jun. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.428/2.571*91
=30.38

2. In Ben Graham's calculation of liquidation value, NanoRepro AG's accounts receivable are only considered to be worth 75% of book value:

NanoRepro AG's liquidation value for the quarter that ended in Jun. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=7.29-0.694+0.75 * 0.428+0.5 * 0.466
=7.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NanoRepro AG Change In Receivables Related Terms

NanoRepro AG Change In Receivables Historical Data

* Premium members only.

The historical data trend for NanoRepro AG's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NanoRepro AG Change In Receivables Chart

NanoRepro AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NanoRepro AG Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:NN6
70GF Score
NanoRepro AG FRA:NN6
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NanoRepro AG Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of €0.00 Mil mean?
NanoRepro AG (FRA:NN6) has a Change In Receivables of €0.00 Mil as of Jun. 2025. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for NanoRepro AG and its competitors.
Is NanoRepro AG's Change In Receivables too high?
NanoRepro AG's current Change In Receivables is €0.00 Mil. Overall, NanoRepro AG has a GF Score™ of 70/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NanoRepro AG's Change In Receivables compare to TMO and DHR?
NanoRepro AG's Change In Receivables of €0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Medical Diagnostics & Research company?
A good Change In Receivables depends on the Medical Diagnostics & Research industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for NanoRepro AG and its competitors. NanoRepro AG's current Change In Receivables is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NanoRepro AG stock overvalued right now?
Based on GuruFocus' analysis, NanoRepro AG (FRA:NN6) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.07, compared to a current price of €1.78 — trading 66.4% above its estimated fair value. The current Change In Receivables is €0.00 Mil. NanoRepro AG's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For NanoRepro AG (FRA:NN6), the current Change In Receivables is €0.00 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NanoRepro AG (FRA:NN6) Overvalued in 2026?

Based on GuruFocus' analysis, NanoRepro AG stock appears to be overvalued. The current stock price of €1.78 is trading 66.4% above its estimated GF Value™ of €1.07. GuruFocus considers NanoRepro AG to be Significantly Overvalued.

Key valuation signals for FRA:NN6:

  • Change In Receivables: €0.00 Mil
  • GF Value™: €1.07 vs. price of €1.78 (66.4% above fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the FRA:NN6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NanoRepro AG Business Description

Other Exchanges NN6:Germany
Address Untergasse 8, Marburg, DEU, 35037
NanoRepro AG is engaged in the development, manufacturing, and distribution of CE-certified rapid diagnostic tests (self-tests) and food supplements for both, home and professional use.
70GF Score

Get the complete analysis for FRA:NN6

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.78
Price
€1.07
GF Value